non-specific chronic low back pain.
Conditions
Interventions
Intervention group: The intervention involves transcranial direct current stimulation (tDCS) using the Medina Teb Neurostim2 device, manufactured in Iran. Two rubber electrodes in sponge pads soaked i
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Female Age Range 18 to 45 years Right-handed At least a high school diploma or higher The pain is predominantly localized in the posterior region, extending from the lateral aspect below the twelfth rib to the inferior gluteal fold. There are no accompanying radicular symptoms or sensory deficits. This pain occurs more than three days per week and has persisted for a minimum duration of three months The Hospital Anxiety and Depression Scale score is 7 or lower. Additionally, there is no cognitive impairment, as evidenced by a Mini-Mental State Examination (MMSE) score of 24 or higher
Exclusion criteria
Exclusion criteria: Infections, Spinal Tumors, Cancer, Rheumatic Diseases, Acute trauma, including fractures, within the past six months, Presence of deformities in the spine or lower extremities, such as scoliosis or kyphosis, No history of spinal, lower limb, neurological, or abdominal surgeries within the past six months Implanted metal devices in the brain, pacemaker, no history of seizures, or use of medications that lower the seizure threshold Pregnancy Recent active treatment or routine use of analgesics and any medication affecting cognitive function Participant's unwillingness to perform or continue the test Consumption of stimulants such as coffee, alcohol, and carbonated beverages before test sessions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neurocognitive parameters in this study include visual and auditory reaction times, as well as anticipatory skills, which are considered measures for assessing neurocognitive performance. Timepoint: Before and after the first session, the fifth session, and one month later. Method of measurement: Using the Speed Anticipation Reaction Time (SART) software. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Before and after the first session, the fifth session, and one month later. Method of measurement: Visual Analogue Scale.;Muscle, Sclerotome, and Dermatome Pressure Pain Thresholds. Timepoint: Before and after the first session, the fifth session, and one month later. Method of measurement: Using a Pressure Algometer.;???????? ?????? ? ?????. Timepoint: Before the first session, the fifth session, and one month later. Method of measurement: Scores from the Depression, Anxiety, and Stress scale(DASS).;Disability. Timepoint: Before the first session, the fifth session, and one month later. Method of measurement: Scores from the Roland-Morris Disability Questionnaire (RMDQ).;Quality of Life. Timepoint: Before the first session, the fifth session, and one month later. Method of measurement: ???????? ? ??? ???? ????? ????? ?????. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSobhan Amiri
Tehran University of Medical Sciences
Outcome results
None listed